In CLL, high expression of HVEM was also demonstrated, which may indicate that cells engage in BTLA/HVEM interaction to inhibit T cell responses and are engaged in immunosuppression of this population of immune cells. The gene discussed is TNFRSF14; the disease is B-cell chronic lymphocytic leukemia.